Offer It: Third-Line Therapy Effective in Metastatic RCCOffer It: Third-Line Therapy Effective in Metastatic RCC

Third-line therapy is prevalent, has demonstrated activity in metastatic renal cell carcinoma (RCC), and should be offered to eligible patients. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news